Related Experiment Video
Updated: Mar 31, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Global gene analysis identifying genes commonly regulated by the Ras/Raf/MEK and type I IFN pathways
Y Komatsu1, K Hirasawa1, S L Christian2
1Division of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, Canada.
Abstract:
Oncolytic viruses exploit alterations in cancer cells to specifically infect cancer cells but not normal healthy cells. Previous work has shown that oncogenic Ras interferes with interferon (IFN) signaling to promote viral replication. Furthermore, inhibition of the Ras/Raf/MEK/ERK pathway at the level of Ras, MEK, or ERK was sufficient to restore IFN signaling. In order to identify genes that were commonly regulated by the inhibition of the Ras pathway and the IFN pathway, we treated NIH/3T3 cells that overexpress oncogenic Ras with the MEK inhibitor, U0126, or IFN-α for 6 h, and performed DNA microarray analysis (Gene Expression Omnibus accession number GSE49469). Here, we also provide additional information on the experimental and functional analysis of the genes responsive to U0126 and IFN.
Insights
Oncolytic viruses target cancer cells by exploiting Ras pathway interference with interferon (IFN) signaling. Inhibiting this pathway restores IFN signaling, identifying key genes for viral therapy.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Oncolytic viruses selectively infect cancer cells, leveraging their unique cellular alterations.
- Oncogenic Ras disrupts interferon (IFN) signaling, promoting viral replication in cancer cells.
- Ras/Raf/MEK/ERK pathway inhibition restores IFN signaling, suggesting therapeutic potential.
Purpose of the Study:
- To identify genes commonly regulated by Ras pathway inhibition and IFN pathway activation.
- To understand the interplay between oncogenic Ras signaling and IFN response in cancer cells.
- To explore potential therapeutic targets for enhancing oncolytic virotherapy.
Main Methods:
- NIH/3T3 cells overexpressing oncogenic Ras were treated with MEK inhibitor U0126 or IFN-α.
- DNA microarray analysis was performed after 6 hours of treatment (GEO accession: GSE49469).
- Experimental and functional analysis of responsive genes was conducted.
Main Results:
- Identified a set of genes commonly regulated by MEK inhibition and IFN-α treatment.
- Demonstrated that inhibiting the Ras pathway can restore IFN signaling in cancer cells.
- Provided data on the specific genes affected by these treatments.
Conclusions:
- The study elucidates gene expression changes resulting from combined Ras pathway inhibition and IFN signaling.
- Findings contribute to understanding how to enhance oncolytic virus efficacy by modulating host cell signaling.
- The identified genes represent potential targets for improving cancer virotherapy.
Related Concept Videos
MAPK Signaling Cascades
The Ras Gene
Ras is a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

